Brendon Frank

442 total citations
10 papers, 238 citations indexed

About

Brendon Frank is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Brendon Frank has authored 10 papers receiving a total of 238 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 4 papers in Molecular Biology and 3 papers in Oncology. Recurrent topics in Brendon Frank's work include Mast cells and histamine (3 papers), CAR-T cell therapy research (3 papers) and Immunotherapy and Immune Responses (3 papers). Brendon Frank is often cited by papers focused on Mast cells and histamine (3 papers), CAR-T cell therapy research (3 papers) and Immunotherapy and Immune Responses (3 papers). Brendon Frank collaborates with scholars based in United States, Japan and France. Brendon Frank's co-authors include Kenneth C. Fang, George H. Caughey, Paul Dazin, Jacques J. Peschon, Anthony Cruz, Holger Wesche, Angela Coxon, Shyun Li, Lawrence Chinn and Fanny Polesso and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and The Journal of Immunology.

In The Last Decade

Brendon Frank

10 papers receiving 235 citations

Peers

Brendon Frank

IMMUN

MB

ONCOL

IA

GENET

Karen Kaucic United States

le-Ming Shih United States

A Superti‐Furga Switzerland

Rudin Kondo Austria

Anand Jacob United States

Yurika Nosaka Japan

Elisa Agnese Nigro Italy

Srimathi Srinivasan United States

Sophie Duchez France

Ursula Jeffry United States

Karen Kaucic United States

Brendon Frank

89 ×0.8

IMMUN

177 ×1.8

MB

75 ×1.5

ONCOL

48 ×1.0

IA

14 ×0.5

GENET

Citations per year, relative to Brendon Frank Brendon Frank (= 1×) peers Karen Kaucic

Countries citing papers authored by Brendon Frank

Since Specialization

Citations

This map shows the geographic impact of Brendon Frank's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brendon Frank with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brendon Frank more than expected).

Fields of papers citing papers by Brendon Frank

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brendon Frank. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brendon Frank. The network helps show where Brendon Frank may publish in the future.

Co-authorship network of co-authors of Brendon Frank

This figure shows the co-authorship network connecting the top 25 collaborators of Brendon Frank. A scholar is included among the top collaborators of Brendon Frank based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brendon Frank. Brendon Frank is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Kamperschroer, Cris, Brendon Frank, Hervé Lebrec, et al.. (2023). Current approaches to evaluate the function of cytotoxic T-cells in non-human primates. Journal of Immunotoxicology. 20(1). 2176952–2176952. 2 indexed citations

2.

Frank, Brendon, et al.. (2021). Application of a newly-developed cynomolgus macaque BiTE-mediated cytotoxic T-lymphocyte activity assay to various immunomodulatory agents in vitro. Journal of Immunotoxicology. 18(1). 154–162. 1 indexed citations

3.

Goldstein, Rebecca, Brendon Frank, Chi-Ming Li, et al.. (2020). Nonclinical Safety Assessment of AMG 553, an Investigational Chimeric Antigen Receptor T-Cell Therapy for the Treatment of Acute Myeloid Leukemia. Toxicological Sciences. 177(1). 94–107. 15 indexed citations

4.

Goldstein, Rebecca, Brendon Frank, Chi-Ming Li, et al.. (2019). Nonclinical safety assessment of AMG 553, an investigational anti-FLT3 CAR-T therapy.. Journal of Clinical Oncology. 37(15_suppl). 7032–7032. 3 indexed citations

5.

Frank, Brendon, Kyung-Hoon Kim, Abraham Guerrero, et al.. (2018). Development of a BiTE^®-mediated CD8⁺cytotoxic T-lymphocyte activity assay to assess immunomodulatory potential of drug candidates inCynomolgusmacaque. Journal of Immunotoxicology. 15(1). 119–125. 3 indexed citations

6.

Horst, Edward H. van der, Brendon Frank, Lawrence Chinn, et al.. (2008). The Growth Factor Midkine Antagonizes VEGF Signaling In Vitro and In Vivo. Neoplasia. 10(4). 340–IN3. 31 indexed citations

7.

Beck, Hilary P., Todd J. Kohn, Steven M. Rubenstein, et al.. (2007). Discovery of potent LPA2 (EDG4) antagonists as potential anticancer agents. Bioorganic & Medicinal Chemistry Letters. 18(3). 1037–1041. 36 indexed citations

8.

Cruz, Anthony, et al.. (2004). Tumor Necrosis Factor-α-converting Enzyme Controls Surface Expression of c-Kit and Survival of Embryonic Stem Cell-derived Mast Cells. Journal of Biological Chemistry. 279(7). 5612–5620. 50 indexed citations

9.

Frank, Brendon, et al.. (2002). Mast Cell α-Chymase Reduces IgE Recognition of Birch Pollen Profilin by Cleaving Antibody-Binding Epitopes. The Journal of Immunology. 168(1). 290–297. 28 indexed citations

10.

Frank, Brendon, et al.. (2001). Mast Cell Tissue Inhibitor of Metalloproteinase-1 Is Cleaved and Inactivated Extracellularly by α-Chymase. The Journal of Immunology. 166(4). 2783–2792. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact